Macular Degeneration: Preclinical Data

Preclinical Data from REGENXBIO RGX-314 Gene Therapy Program for Wet Age-Related Macular Degeneration to be Presented at Upcoming Conferences Preclinical data for RGX-314 program for the treatment of wet AMD to be presented at the… read more →